Background: One of the important success stories in pharmaceuticals has been the British company Shire plc (NASDAQ:SHPG). Here is the long term chart:
(click to enlarge)
Shire is a large cap worth $33 billion. In 2005, it spun off a U.S. subsidiary which had a focus on controlled release (CR) technologies and on central nervous treatments. The company, Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), has made substantial progress lately, and is in my opinion a stock many growth investors may want to follow or own. SUPN's market cap is right around 1% that of its parent, at $346 MM.
Having a background both in controlled release products and in specialty pharma, I have a high degree of...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|